Cathie Wood’s Top 5 Small-Cap Stock Picks

Page 5 of 5

1. Editas Medicine, Inc. (NASDAQ:EDIT)

ARK Investment Management’s Stake Value: $406,678,000

Percentage of ARK Investment Management’s 13F Portfolio: 0.75%

Market Cap: $2.595 billion

Number of Hedge Fund Holders: 23

Ranking first on our list of Cathie Wood’s top 15 small-cap stock picks is Editas Medicine, Inc. (NASDAQ:EDIT), which is a biotechnology company focused on genome editing, and the potential of genomic technology into medicines that can combat deadly diseases. The company is employing CRISPR technology to edit genes on the inside and outside the human body. 

Wood’s ARK Investment Management owns 7.18 million shares in  Editas Medicine, Inc. (NASDAQ:EDIT), worth $406.6 million, representing 0.75% of Wood’s 13F portfolio. 

With ARK Investment Management as the leading stakeholder, overall, 25 hedge funds were bullish on  Editas Medicine, Inc. (NASDAQ:EDIT) at the end of June according to Insider Monkey’s database, down from 24 in the previous quarter. 

On August 4, the earnings per share for the second quarter amounted to -$0.81, exactly as analysts’ predicted. The revenue for  Editas Medicine, Inc. (NASDAQ:EDIT) was $379,000, missing estimates by -$6.4 million. 

Stifel analyst Dae Gon Ha kept a Hold rating on the stock, while lowering the price target from $65 to $46. He was on the fence about the pipeline value and success of some of the upcoming products at  Editas Medicine, Inc. (NASDAQ:EDIT), hence the lowered price target and subsequent rating. 

You can also take a look at 11 Best 5G Stocks To Buy According To Hedge Funds and Carl Icahn’s Stock Portfolio: Top 12 Picks

Page 5 of 5